In-hospital mortality following treatment with red blood cell transfusion or inotropic therapy during early goal-directed therapy for septic shock: a retrospective propensity-adjusted analysis
Open Access
- 12 September 2014
- journal article
- research article
- Published by Springer Nature in Critical Care
- Vol. 18 (5) , 496
Abstract
Introduction: We sought to investigate whether treatment of subnormal (2) with inotropes or red blood cell (RBC) transfusion during early goal-directed therapy (EGDT) for septic shock is independently associated with in-hospital mortality. Methods: Retrospective analysis of a prospective EGDT patient database drawn from 21 emergency departments with a single standardized EGDT protocol. Patients were included if, during EGDT, they concomitantly achieved a central venous pressure (CVP) of ≥8 mm Hg and a mean arterial pressure (MAP) of ≥65 mm Hg while registering a ScvO2 < 70%. Treatment propensity scores for either RBC transfusion or inotrope administration were separately determined from independent patient sub-cohorts. Propensity-adjusted logistic regression analyses were conducted to test for associations between treatments and in-hospital mortality. Results: Of 2,595 EGDT patients, 572 (22.0%) met study inclusion criteria. The overall in-hospital mortality rate was 20.5%. Inotropes or RBC transfusions were administered for an ScvO2 < 70% to 51.9% of patients. Patients were not statistically more likely to achieve an ScvO2 of ≥70% if they were treated with RBC transfusion alone (29/59, 49.2%, P = 0.19), inotropic therapy alone (104/226, 46.0%, P = 0.15) or both RBC and inotropic therapy (7/12, 58.3%, P = 0.23) as compared to no therapy (108/275, 39.3%). Following adjustment for treatment propensity score, RBC transfusion was associated with a decreased adjusted odds ratio (aOR) of in-hospital mortality among patients with hemoglobin values less than 10 g/dL (aOR 0.42, 95% CI 0.18 to 0.97, P = 0.04) while inotropic therapy was not associated with in-hospital mortality among patients with hemoglobin values of 10 g/dL or greater (aOR 1.16, 95% CI 0.69 to 1.96, P = 0.57). Conclusions: Among patients with septic shock treated with EGDT in the setting of subnormal ScvO2 values despite meeting CVP and MAP target goals, treatment with RBC transfusion may be independently associated with decreased in-hospital mortality.Keywords
This publication has 58 references indexed in Scilit:
- Improvement in process of care and outcome in patients requiring intensive care unit admission for community acquired pneumoniaBMC Infectious Diseases, 2013
- Shock Index and Early Recognition of Sepsis in the Emergency Department: Pilot StudyWestern Journal of Emergency Medicine, 2013
- Liberal or Restrictive Transfusion in High-Risk Patients after Hip SurgeryNew England Journal of Medicine, 2011
- Red blood cell transfusion and outcomes in patients with acute lung injury, sepsis and shockCritical Care, 2011
- Vasopressors and Inotropes in the Treatment of Human Septic Shock: Effect on Innate Immunity?Inflammation, 2011
- The effect of red blood cell transfusion on tissue oxygenation and microcirculation in severe septic patientsAnnals of Intensive Care, 2011
- Lactate Clearance vs Central Venous Oxygen Saturation as Goals of Early Sepsis TherapyA Randomized Clinical TrialJAMA, 2010
- A Modification of the Elixhauser Comorbidity Measures Into a Point System for Hospital Death Using Administrative DataMedical Care, 2009
- The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation*Critical Care Medicine, 2009
- Risk-Adjusting Hospital Inpatient Mortality Using Automated Inpatient, Outpatient, and Laboratory DatabasesMedical Care, 2008